Philadelphia Medical Group

Philadelphia Medical Group operates a regenerative medicine and medical wellness practice in Philadelphia, PA, focusing on evidence-based weight management protocols, body composition optimization, and peptide-based regenerative therapies. The clinic serves patients throughout the greater Philadelphia area with in-person consultations that include comprehensive body analysis using bioelectrical impedance and metabolic rate assessment to establish individualized treatment baselines. This data-driven approach allows providers to track visceral fat reduction, lean muscle preservation, and metabolic improvements throughout treatment protocols.

The clinic's weight loss programs incorporate lipotropic injection therapy combining methionine, inositol, and choline (MIC) to support hepatic fat metabolism, along with methylcobalamin B12 injections administered weekly or biweekly depending on patient response and methylation status. Philadelphia Medical Group offers peptide therapies including CJC-1295 and ipamorelin for growth hormone optimization in patients with documented deficiencies, BPC-157 for tissue repair and gastrointestinal healing, and thymosin alpha-1 for immune system modulation. Treatment plans typically combine nutritional counseling with macronutrient targets specific to each patient's metabolic profile, injection therapy protocols ranging from weekly to twice-monthly administration, and follow-up body composition analysis at 4-6 week intervals to adjust dosing and nutritional parameters based on objective measurements.

The medical team includes physicians trained in functional and regenerative medicine who conduct initial consultations lasting 45-60 minutes to review medical history, current medications, hormone panels, and metabolic markers before designing treatment protocols. Providers order baseline laboratory work including comprehensive metabolic panels, lipid profiles, thyroid function tests, and hormone assessments when clinically indicated to identify underlying factors affecting weight regulation and metabolic function. The clinic's approach addresses insulin resistance, thyroid dysfunction, sex hormone imbalances, and cortisol dysregulation as contributing factors to weight gain and metabolic syndrome, rather than treating obesity as an isolated caloric imbalance.

Patients beginning treatment at Philadelphia Medical Group undergo an initial body composition analysis measuring body fat percentage, skeletal muscle mass, basal metabolic rate, and visceral fat level to establish quantifiable metrics for tracking progress. The clinic schedules injection appointments at regular intervals based on the specific protocol prescribed, with most patients visiting weekly during the initial 8-12 week intensive phase. Follow-up consultations occur monthly during active weight loss and include repeat body analysis, review of food logs, assessment of energy levels and side effects, and protocol adjustments based on rate of fat loss and muscle preservation. The practice emphasizes sustainable metabolic changes rather than rapid weight loss, targeting 1-2 pounds of fat loss weekly while maintaining or increasing lean body mass through adequate protein intake and resistance exercise recommendations.

Located in Philadelphia, PA, Philadelphia Medical Group maintains a 4.9-star rating across 29 Google reviews, with patients specifically noting results in weight reduction, personalized goal-setting, and the clinical injection protocols. The practice requires in-person visits for all consultations and injection administration, allowing providers to monitor injection site reactions, assess patient response, and adjust treatment plans based on direct clinical observation. This hands-on approach enables the medical team to identify patients who may benefit from additional interventions such as prescription appetite suppressants, GLP-1 receptor agonists for patients meeting clinical criteria, or advanced peptide combinations for those with plateau in results despite protocol adherence.